HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Se Hyun Kim Selected Research

Neuroinflammatory Diseases

1/2019Bee venom phospholipase A2 ameliorates amyloidogenesis and neuroinflammation through inhibition of signal transducer and activator of transcription-3 pathway in Tg2576 mice.
1/2019Bee Venom Soluble Phospholipase A2 Exerts Neuroprotective Effects in a Lipopolysaccharide-Induced Mouse Model of Alzheimer's Disease via Inhibition of Nuclear Factor-Kappa B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Se Hyun Kim Research Topics

Disease

42Neoplasms (Cancer)
10/2022 - 09/2007
25Schizophrenia (Dementia Praecox)
01/2021 - 12/2005
24Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2022 - 01/2007
16Breast Neoplasms (Breast Cancer)
10/2022 - 09/2007
13Bipolar Disorder (Manic Depressive Psychosis)
01/2021 - 06/2007
9Neoplasm Metastasis (Metastasis)
09/2019 - 02/2009
7Colorectal Neoplasms (Colorectal Cancer)
11/2022 - 01/2012
6Mood Disorders (Mood Disorder)
12/2021 - 02/2010
6Psychotic Disorders (Schizoaffective Disorder)
11/2020 - 06/2007
5Disease Progression
10/2022 - 01/2007
5Major Depressive Disorder (Major Depressive Disorders)
12/2021 - 01/2016
5Mental Disorders (Mental Disorder)
12/2021 - 06/2007
5Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2019 - 10/2010
5Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2018 - 07/2011
4Inflammation (Inflammations)
03/2022 - 01/2019
4Depressive Disorder (Melancholia)
02/2022 - 06/2011
4Carcinoma (Carcinomatosis)
12/2020 - 04/2003
4Lung Neoplasms (Lung Cancer)
09/2019 - 01/2018
4Mania (Manias)
08/2013 - 09/2009
3Stomach Neoplasms (Stomach Cancer)
01/2020 - 01/2016
3Treatment-Resistant Schizophrenia
01/2019 - 05/2008
2Pneumonia (Pneumonitis)
03/2022 - 11/2018
2Obesity
03/2022 - 01/2014
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2022 - 07/2017
2Lymphoma (Lymphomas)
12/2021 - 11/2019
2Adenocarcinoma of Lung
02/2021 - 09/2017
2Seizures (Absence Seizure)
10/2020 - 09/2014
2Hallucinations (Hallucination)
05/2019 - 11/2012
2Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature
03/2019 - 03/2015
2Neuroinflammatory Diseases
01/2019 - 01/2019
2Alzheimer Disease (Alzheimer's Disease)
01/2019 - 01/2019

Drug/Important Bio-Agent (IBA)

13Biomarkers (Surrogate Marker)IBA
10/2022 - 07/2011
13Antipsychotic Agents (Antipsychotics)IBA
01/2021 - 08/2006
10Clozapine (Clozaril)FDA LinkGeneric
03/2022 - 11/2006
8Immune Checkpoint InhibitorsIBA
10/2022 - 11/2018
8Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2016
8ErbB Receptors (EGF Receptor)IBA
02/2021 - 07/2011
6Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 10/2017
5taxaneIBA
04/2022 - 09/2007
5Pharmaceutical PreparationsIBA
03/2022 - 09/2009
5Cisplatin (Platino)FDA LinkGeneric
01/2021 - 08/2012
5PlatinumIBA
10/2019 - 10/2015
4Cetuximab (Erbitux)FDA Link
11/2022 - 01/2007
4Blood Proteins (Serum Proteins)IBA
01/2022 - 01/2016
4Irinotecan (Camptosar)FDA LinkGeneric
01/2021 - 10/2010
4GemcitabineFDA Link
01/2021 - 01/2012
4Phenobarbital (Luminal)FDA Link
11/2018 - 06/2017
4Ouabain (G Strophanthin)IBA
08/2013 - 10/2008
3Indicators and Reagents (Reagents)IBA
10/2022 - 10/2018
3Estrogen ReceptorsIBA
10/2022 - 06/2018
3Tyrosine Kinase InhibitorsIBA
02/2021 - 10/2015
3DNA (Deoxyribonucleic Acid)IBA
01/2021 - 04/2003
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 09/2007
3Aripiprazole (Abilify)FDA Link
11/2020 - 05/2008
3Pemetrexed (MTA)FDA Link
11/2019 - 10/2015
3Anaplastic Lymphoma KinaseIBA
11/2019 - 10/2017
3Etoposide (VP 16)FDA LinkGeneric
10/2019 - 08/2012
3Bee Venoms (Bee Venom)IBA
01/2019 - 01/2019
3Phospholipases A2 (Phospholipase A2)IBA
01/2019 - 01/2019
3eribulinFDA Link
01/2019 - 04/2017
3thiamine triphosphorate (TTP)IBA
11/2018 - 01/2016
3Progesterone Receptors (Progesterone Receptor)IBA
11/2018 - 06/2018
3Hormones (Hormone)IBA
11/2018 - 10/2016
3Carcinoembryonic AntigenIBA
11/2014 - 07/2011
3ATPase Inhibitory ProteinIBA
08/2013 - 10/2008
3Gefitinib (Iressa)FDA Link
03/2013 - 07/2011
3Dizocilpine Maleate (Dizocilpine)IBA
10/2010 - 12/2005
3Glycogen Synthase Kinase 3 betaIBA
06/2007 - 12/2005
2RNA (Ribonucleic Acid)IBA
10/2022 - 11/2019
2Inosine Triphosphate (ITP)IBA
01/2022 - 07/2017
2Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
12/2021 - 10/2015
2B7-H1 AntigenIBA
02/2021 - 01/2016
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 10/2016
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 04/2010
2Peptides (Polypeptides)IBA
10/2020 - 01/2019
2LigandsIBA
10/2020 - 07/2019
2AlpelisibIBA
09/2020 - 01/2020
2Phosphotransferases (Kinase)IBA
11/2019 - 05/2010
2CytokinesIBA
01/2019 - 09/2017
2EnzymesIBA
01/2019 - 10/2017
2human ERBB2 proteinIBA
06/2018 - 10/2016
2LipidsIBA
01/2018 - 05/2016
2NivolumabIBA
01/2018 - 01/2018
2Antidepressive Agents (Antidepressants)IBA
01/2017 - 11/2012
2Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
02/2016 - 04/2014
2HDL CholesterolIBA
10/2014 - 10/2010
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
09/2014 - 06/2007
2Risperidone (Risperdal Consta)FDA LinkGeneric
09/2014 - 07/2011
2LithiumIBA
12/2013 - 04/2012

Therapy/Procedure

34Drug Therapy (Chemotherapy)
04/2022 - 01/2007
14Therapeutics
10/2022 - 09/2007
5Neoadjuvant Therapy
01/2021 - 09/2007
3Aftercare (After-Treatment)
12/2019 - 11/2009
2Palliative Care (Palliative Therapy)
04/2022 - 03/2020
2Immunotherapy
04/2022 - 09/2017
2Chemoradiotherapy
09/2019 - 08/2012
2Induction Chemotherapy
09/2019 - 08/2012
2Radiotherapy
09/2019 - 02/2009
2Length of Stay
07/2019 - 10/2012
2Adjuvant Radiotherapy
10/2018 - 06/2017